Author:
Dykstra Kevin,Mehrotra Nitin,Tornøe Christoffer Wenzel,Kastrissios Helen,Patel Bela,Al-Huniti Nidal,Jadhav Pravin,Wang Yaning,Byon Wonkyung
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Sheiner LB, Beal SL (1980) Evaluation of methods for estimating population pharmacokinetic parameters I. Michaelis-menten model: routine clinical pharmacokinetic data. J Pharmacokin Biopharm 1980:553–571
2. Romero K, Corrigan B, Tornøe CW, Gobburu JV, Danhof M, Gillespie WR, Gastonguay MR, Meibohm B, Derendorf H (2010) Pharmacometrics as a discipline is entering the “industrialization” phase: standards, automation, knowledge sharing, and training are critical for future success. J Clin Pharmacol 50:9S–19S
3. US Food and Drug Administration (1999) Guidance for industry: population pharmacokinetics. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072137.pdf . Accessed 30 Mar 2014
4. Wade JR, Edholm M, Salmonson T (2005) A guide for reporting the results of population pharmacokinetic analyses: a Swedish perspective. AAPS J 7(2):E456–E460
5. Committee for Medicinal Products for Human Use (2007) Guideline on reporting the results of population pharmacokinetic analyses. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003067.pdf . Accessed 30 Mar 2014
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献